| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.36B | +23.3% |
| Cost of Revenue | $803.5M | +26.8% |
| Gross Profit | $3.56B | +22.6% |
| R&D Expense | $2.18B | +16.8% |
| SG&A Expense | $610.6M | +0.7% |
| Operating Income | -$117.1M | +66.1% |
| Pre-tax Income | -$85.4M | +72.5% |
| Income Tax | $215.1M | +22.5% |
| Net Income | -$300.5M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.18B | +3.5% |
| Short-term Investments | $162.0M | +1519.7% |
| Accounts Receivable | $628.0M | +31.5% |
| Current Assets | $3.08B | +12.4% |
| Total Assets | $5.21B | +26.9% |
| Current Liabilities | $2.61B | +28.7% |
| Long-term Debt | $985.9M | +2.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.45B | +66.8% |
| Capital Expenditures | $32.6M | +27.0% |
| Investing Cash Flow | -$963.7M | — |
| Financing Cash Flow | -$408.2M | -175.0% |
| Free Cash Flow | $1.42B | +68.0% |
| +38.3% |
| EPS (Basic) | -$1.16 | +38.9% |
| EPS (Diluted) | -$1.16 | +38.9% |
| Total Liabilities |
| $4.18B |
| +21.1% |
| Stockholders' Equity | $1.03B | +57.8% |